Diabetic macular edema: OCT retinal biomarkers as predictive factors of treatment response and long-term visual outcome

Diabetic retinopathy (DR) is the leading cause of blindness in working-aged people worldwide[1]. Diabetic macular edema (DME) occurs in nearly 12% of patients with DR and represents a frequent complication of diabetes resulting from disruption of blood-retinal barrier and accumulation of fluid in the retina, which can lead to significant central visual loss if left untreated[2]. Read more